Advancing next-generation heart repair requires collaboration. We work with leading research institutions, clinicians, and industry partners to accelerate the development of regenerative cardiac therapies.
Our Partners
Novo Nordisk Foundation Cellerator
The Novo Nordisk Foundation Cellerator is helping build the infrastructure needed to translate promising cell therapies from the laboratory toward first-in-human readiness. Its focus on process development, scale-up, and clinical translation makes it a key partner as we advance our manufacturing and CMC pathway toward the clinic.
BioInnovation Institute
BioInnovation Institute supports the translation of breakthrough life science innovation into venture-backed companies with the potential to create real patient impact. Through this partnership, Ibnova is strengthening its company-building, commercial, and fundraising foundations alongside the development of our therapeutic platform.
The Alfred Hospital
At The Alfred, we are partnered with leading cardiac surgeons and heart failure transplant cardiologists to help shape the future clinical translation of our therapy. This collaboration brings critical frontline expertise in advanced heart failure, surgical implementation, and the realities of treating patients with severe cardiac disease.
Royal Children’s Hospital Melbourne
At the Royal Children’s Hospital Melbourne, we are partnered with leading cardiac surgeons and heart failure transplant cardiologists whose expertise helps inform the translational and clinical vision for our platform. Their involvement strengthens our connection to world-class clinical care and the development of therapies designed for meaningful patient impact.
Murdoch Children’s Research Institute
At Murdoch Children’s Research Institute, we are partnered with the Heart Regeneration Lab for its expertise in cardiac stem cell biology and regeneration. This collaboration brings deep scientific insight into the mechanisms of cardiac repair and supports the continued advancement of our regenerative therapeutic strategy.
QIMR Berghofer
At QIMR Berghofer, we are partnered with the Cardiac Bioengineering Lab for its expertise in bioengineering, material science, and cardiovascular mechanics and biology. This collaboration provides a strong scientific foundation for the design, optimization, and translational development of our engineered heart patch platform.
Baker Heart and Diabetes Institute
At the Baker Heart and Diabetes Institute, we are partnered with the Translational Cardiology Centre for its expertise in preclinical animal modeling. This collaboration strengthens our translational pathway by supporting the rigorous preclinical evaluation of our platform in clinically relevant cardiovascular disease models.